Amygdala Neurosciences, Inc.

Gilead Sciences, Inc.

Gilead Palo Alto, Inc.

Brent Blackburn

Luiz Belardinelli

Andrew A Wolff

Charles Antzelevitch

Marcus Jerling

Hsiao D Lieu

Disclosed herein are aldehyde dehydrogenase (ALDH-2) inhibitor compounds, such as a compounds of Formula (I) or Formula (II), pharmaceutical compositions comprising these inhibitor compounds, and uses of these compounds and compositions, such as in the methods for safely treating chemical dependency on a substance or condition of addiction, such as alcohol, nicotine, cocaine, opiates, amphetamines, and and compulsive eating disorder, and/or anxiety disorder, each individually or concurrent.

ALDH-2 inhibitor compounds and methods of use

Disclosed herein are aldehyde dehydrogenase (ALDH-2) inhibitor compounds, such as a compounds of Formula (I) or Formula (II), pharmaceutical compositions comprising these inhibitor compounds, and uses of these compounds and compositions, such as in the methods for safely treating chemical dependency on a substance or condition of addiction, such as alcohol, nicotine, cocaine, opiates, amphetamines, and compulsive eating disorder, and/or anxiety disorder, each individually or concurrent.

Growing community of inventors

Los Altos, CA, United States of America

Brent Blackburn